MILIND JAVLE to Cohort Studies
This is a "connection" page, showing publications MILIND JAVLE has written about Cohort Studies.
Connection Strength
0.072
-
Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. JAMA Surg. 2020 09 01; 155(9):832-839.
Score: 0.019
-
Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic Cancer. Clin Cancer Res. 2020 03 15; 26(6):1385-1394.
Score: 0.018
-
Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study. Ann Surg. 2015 Apr; 261(4):733-9.
Score: 0.013
-
Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer. Cancer Chemother Pharmacol. 2007 Apr; 59(5):581-7.
Score: 0.007
-
Cyclooxygenase-2 (COX-2) levels before and after chemotherapy: a study in rectal cancer. Am J Clin Oncol. 2005 Dec; 28(6):560-4.
Score: 0.007
-
Risk factors associated with earlier age of onset in familial pancreatic carcinoma. Cancer. 2004 Dec 15; 101(12):2722-6.
Score: 0.006